カテゴリ： Transparency Market Research, 世界, 医療/バイオ

急性呼吸窮迫症候群デバイスの世界市場（2022～2031）：種類別

■ 英語タイトル：Acute Respiratory Distress Syndrome Devices Market (Type: Therapeutic Devices and Diagnostic & Monitoring Devices) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

調査会社Transparency Market Research社が発行したリサーチレポート（データ管理コード：TMR23AP079）■ 発行会社/調査会社：Transparency Market Research
■ 商品コード：TMR23AP079
■ 発行日：2023年1月25日
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：183
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥880,840見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,336,840見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,792,840見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Transparency Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[急性呼吸窮迫症候群デバイスの世界市場（2022～2031）：種類別]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Transparency Market Research社の本調査レポートでは、急性呼吸窮迫症候群デバイスの世界市場について総合的に分析し、今後の市場動向を予測しています。本書は、序論、仮定＆調査手法、エグゼクティブサマリー、市場概要、キーインサイト、種類別（治療用デバイス、診断＆モニタリング用デバイス）分析、エンドユーザー別（病院、専門センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの項目が整理されています。また、本書内には、Koninklijke Philips N.V.、Medtronic、Fisher & Paykel Healthcare Limited、Drägerwerk AG & Co. KGaA、Smiths Medical (ICU Medical)、Hamilton Medical、GE HealthCare、ResMed、Getinge ABなどの企業情報が含まれています。
・序論
・仮定＆調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界の急性呼吸窮迫症候群デバイス市場規模：種類別
- 急性呼吸窮迫症候群治療用デバイスの市場規模
- 急性呼吸窮迫症候群診断＆モニタリング用デバイスの市場規模
・世界の急性呼吸窮迫症候群デバイス市場規模：エンドユーザー別
- 病院における市場規模
- 専門センターにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の急性呼吸窮迫症候群デバイス市場規模：地域別
- 北米の急性呼吸窮迫症候群デバイス市場規模
- ヨーロッパの急性呼吸窮迫症候群デバイス市場規模
- アジア太平洋の急性呼吸窮迫症候群デバイス市場規模
- 中南米のアルミニウムスラグ市場規模
- 中東・アフリカのアルミニウムスラグ市場規模
・競争状況

Acute Respiratory Distress Syndrome Devices Market – Scope of Report
TMR’s report on the global acute respiratory distress syndrome devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global acute respiratory distress syndrome devices market for the period 2017–2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global acute respiratory distress syndrome devices market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the acute respiratory distress syndrome devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global acute respiratory distress syndrome devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global acute respiratory distress syndrome devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global acute respiratory distress syndrome devices market.

The report delves into the competitive landscape of the global acute respiratory distress syndrome devices market. Key players operating in the global acute respiratory distress syndrome devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global acute respiratory distress syndrome devices market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market acute respiratory distress syndrome devices.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

• Industry Sources:
o WorldWideScience.org
o Elsevier, Inc.
o National Institutes of Health (NIH)
o PubMed
o NCBI
o Department of Health Care Service
• Trade Data Sources
o Trade Map
o UN Comtrade
o Trade Atlas
• Company Information
o OneSource Business Browser
o Hoover’s
o Factiva
o Bloomberg
• Mergers & Acquisitions
o Thomson Mergers & Acquisitions
o MergerStat
o Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Acute Respiratory Distress Syndrome Devices Market
4. Market Overview
    4.1. Overview
    4.2. Market Dynamics
        4.2.1. Drivers
        4.2.2. Restraints
        4.2.3. Opportunities
    4.3. Global Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast, 2017–2031
5. Key Insight
    5.1. Disease Incidence and prevalence
    5.2. Key Mergers & Acquisitions
    5.3. New Product Launches and FDA Approvals
    5.4. COVID-19 Impact Analysis
6. Global Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast, by Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Global Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031
        6.3.1. Therapeutic Devices
            6.3.1.1. Mechanical Ventilators
            6.3.1.2. PAP
            6.3.1.3. Others
        6.3.2. Diagnostic & Monitoring Devices
    6.4. Global Acute Respiratory Distress Syndrome Devices Market Attractiveness, by Type
7. Global Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast, by End-user
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Global Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031
        7.3.1. Hospitals
        7.3.2. Specialty Centers
        7.3.3. Others
    7.4. Global Acute Respiratory Distress Syndrome Devices Market Attractiveness, by End-user
8. Global Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast, by Region
    8.1. Key Findings
    8.2. Global Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Region
        8.2.1. North America
        8.2.2. Europe
        8.2.3. Asia Pacific
        8.2.4. Latin America
        8.2.5. Middle East & Africa
    8.3. Global Acute Respiratory Distress Syndrome Devices Market Attractiveness, by Region
9. North America Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast
    9.1. Introduction
        9.1.1. Key Findings
    9.2. North America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031
        9.2.1. Therapeutic Devices
            9.2.1.1. Mechanical Ventilators
            9.2.1.2. PAP
            9.2.1.3. Others
        9.2.2. Diagnostic & Monitoring Devices
    9.3. North America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031
        9.3.1. Hospitals
        9.3.2. Specialty Centers
        9.3.3. Others
    9.4. North America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country, 2017–2031
        9.4.1. U.S.
        9.4.2. Canada
    9.5. North America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis
        9.5.1. By Type
        9.5.2. By End-user
        9.5.3. By Country
10. Europe Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Europe Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031
        10.2.1. Therapeutic Devices
            10.2.1.1. Mechanical Ventilators
            10.2.1.2. PAP
            10.2.1.3. Others
        10.2.2. Diagnostic & Monitoring Devices
    10.3. Europe Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031
        10.3.1. Hospitals
        10.3.2. Specialty Centers
        10.3.3. Others
    10.4. Europe Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country/Sub-region, 2017–2031
        10.4.1. Germany
        10.4.2. U.K.
        10.4.3. France
        10.4.4. Spain
        10.4.5. Italy
        10.4.6. Rest of Europe
    10.5. Europe Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis
        10.5.1. By Type
        10.5.2. By End-user
        10.5.3. By Country/Sub-region
11. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031
        11.2.1. Therapeutic Devices
            11.2.1.1. Mechanical Ventilators
            11.2.1.2. PAP
            11.2.1.3. Others
        11.2.2. Diagnostic & Monitoring Devices
    11.3. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031
        11.3.1. Hospitals
        11.3.2. Specialty Centers
        11.3.3. Others
    11.4. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country/Sub-region, 2017–2031
        11.4.1. China
        11.4.2. Japan
        11.4.3. India
        11.4.4. Australia & New Zealand
        11.4.5. Rest of Asia Pacific
    11.5. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis
        11.5.1. By Type
        11.5.2. By End-user
        11.5.3. By Country/Sub-region
12. Latin America Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Latin America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031
        12.2.1. Therapeutic Devices
            12.2.1.1. Mechanical Ventilators
            12.2.1.2. PAP
            12.2.1.3. Others
        12.2.2. Diagnostic & Monitoring Devices
    12.3. Latin America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031
        12.3.1. Hospitals
        12.3.2. Specialty Centers
        12.3.3. Others
    12.4. Latin America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country/Sub-region, 2017–2031
        12.4.1. Brazil
        12.4.2. Mexico
        12.4.3. Rest of Latin America
    12.5. Latin America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis
        12.5.1. By Type
        12.5.2. By End-user
        12.5.3. By Country/Sub-region
13. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031
        13.2.1. Therapeutic Devices
            13.2.1.1. Mechanical Ventilators
            13.2.1.2. PAP
            13.2.1.3. Others
        13.2.2. Diagnostic & Monitoring Devices
    13.3. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031
        13.3.1. Hospitals
        13.3.2. Specialty Centers
        13.3.3. Others
    13.4. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country/Sub-region, 2017–2031
        13.4.1. GCC Countries
        13.4.2. South Africa
        13.4.3. Rest of Middle East & Africa
    13.5. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis
        13.5.1. By Type
        13.5.2. By End-user
        13.5.3. By Country/Sub-region
14. Competition Landscape
    14.1. Market Player – Competition Matrix (By Tier and Size of Companies)
    14.2. Market Share Analysis By Company (2021)
    14.3. Company Profiles
        14.3.1. Koninklijke Philips N.V.
            14.3.1.1. Company Overview
            14.3.1.2. Product Portfolio
            14.3.1.3. SWOT Analysis
            14.3.1.4. Financial Overview
            14.3.1.5. Strategic Overview
        14.3.2. Medtronic
            14.3.2.1. Company Overview
            14.3.2.2. Product Portfolio
            14.3.2.3. SWOT Analysis
            14.3.2.4. Financial Overview
            14.3.2.5. Strategic Overview
        14.3.3. Fisher & Paykel Healthcare Limited
            14.3.3.1. Company Overview
            14.3.3.2. Product Portfolio
            14.3.3.3. SWOT Analysis
            14.3.3.4. Financial Overview
            14.3.3.5. Strategic Overview
        14.3.4. Drägerwerk AG & Co. KGaA
            14.3.4.1. Company Overview
            14.3.4.2. Product Portfolio
            14.3.4.3. SWOT Analysis
            14.3.4.4. Financial Overview
            14.3.4.5. Strategic Overview
        14.3.5. Smiths Medical (ICU Medical)
            14.3.5.1. Company Overview
            14.3.5.2. Product Portfolio
            14.3.5.3. SWOT Analysis
            14.3.5.4. Financial Overview
            14.3.5.5. Strategic Overview
        14.3.6. Hamilton Medical
            14.3.6.1. Company Overview
            14.3.6.2. Product Portfolio
            14.3.6.3. SWOT Analysis
            14.3.6.4. Strategic Overview
        14.3.7. GE HealthCare
            14.3.7.1. Company Overview
            14.3.7.2. Product Portfolio
            14.3.7.3. SWOT Analysis
        14.3.8. ResMed
            14.3.8.1. Company Overview
            14.3.8.2. Product Portfolio
            14.3.8.3. SWOT Analysis
            14.3.8.4. Strategic Overview
        14.3.9. Getinge AB
            14.3.9.1. Company Overview
            14.3.9.2. Product Portfolio
            14.3.9.3. SWOT Analysis
            14.3.9.4. Strategic Overview

List of Tables

Table 01: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 02: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031

Table 03: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 06: North America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031

Table 07: North America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 08: North America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 09: Europe Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 10: Europe Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031

Table 11: Europe Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 12: Europe Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 13: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 14: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031

Table 15: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 16: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Latin America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 18: Latin America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031

Table 19: Latin America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 20: Latin America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 21: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 22: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031

Table 23: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 24: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 体外式CO2除去の世界市場2023～2031：製品別、アクセスタイプ別、エンドユーザー別
  • 急性肺損傷治療の世界市場（2022～2031）：治療法別、エンドユーザー別
  • 呼吸器用ディスポーザブル製品の世界市場（2022～2031）：製品別
  • 睡眠ポリグラフ装置の世界市場（2022～2031）：製品別、チャンネル別
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(TMR23AP079 )"急性呼吸窮迫症候群デバイスの世界市場（2022～2031）：種類別" (英文：Acute Respiratory Distress Syndrome Devices Market (Type: Therapeutic Devices and Diagnostic & Monitoring Devices) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031)はTransparency Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。